Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-24 @ 9:46 PM
NCT ID:
NCT05355532
Eligibility Criteria:
Inclusion Criteria:
1. informed consent to participate in the study;
2. male or female 18 years of age or older;
3. type 1 ST-segment elevation MI (according to the criteria of the fourth universal definition of myocardial infarction and current clinical guidelines);
4. blood sampling in the operating room (immediately after PCI) and signing the informed consent;
5. for the "CMVO+" group: CMVO because of PCI (CMVO is registered according to the criteria from the European Society of Cardiology clinical guidelines);
6. for the "CMVO-" group: absence of CMVO after PCI; patient should compliance by sex and age (±5 years) with pair in the "CMVO+" group.
Exclusion Criteria:
1. late admission (more than 48 hours from the onset of anginal pain) or early post-infarction angina pectoris;
2. not 1 type MI;
3. complications during PCI (dissection, perforation or acute intraoperative thrombosis of the IRA);
4. death during PCI, not due to the CMVO development;
5. concomitant terminal pathology (not associated with MI) with a life expectancy less than 1 month.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05355532
Study Brief:
Protocol Section:
NCT05355532